Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
If you’re not yet compliant with DSCSA, here are some practical steps to follow
March 7, 2017
By: john jordon
Vantage Consulting Group
DSCSA. It stands for the Drug Supply Chain Security Act, but if you’re a contract manufacturing organization (CMO) who has procrastinated, it means something along the lines of doomed, scared, cramming and scrambling around. DSCSA is the FDA regulation requiring pharma companies to begin “serializing” all prescription drug products intended for distribution to the U.S. market. That means printing each saleable unit—think carton, tray and individual bottles—and homogeneous shipper (case) with a unique identifier, starting Nov. 27, 2017, at the latest. Serialization is one of the first steps toward making every capsule, vial, tablet or strip traceable through the pharmaceutical supply chain—from origin to destination, whether it’s the drug store or doctor’s office. It’s the first stage of developing a system that will help regulators protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. A great many pharmaceutical manufacturers, CMOs and contract packaging organizations (CPOs) have re-engineered their operations to comply with the regulation. But as it was in high school, a few have not completed the homework, and they’re sweating bullets. A common question is, “I haven’t started serializing, is it too late?” The answer depends on how you think about it. There’s a compliance perspective and a business perspective. Let’s parse them out. From the legal perspective, what are the consequences of missing the deadline? Will there be fines? Sanctions? Extensions? No one but the FDA is qualified to answer, so let’s set those questions aside for now. Now a question for you: What is the business impact if your clients elect to avoid dealing with a contract manufacturer who is clearly missing the DSCSA deadline? Potentially catastrophic, we’d guess. So there really is no too late. If DSCSA applies to you and you’re not on track, start now. The good news is that all is not lost. If you get started on your serialization implementation today and make a good faith effort, it’s reasonable to expect you can get a packaging line, perhaps more, fully serialized by the end of November. This article lays out a strategy for tackling the problem. Although you may be panicking, it doesn’t include a panic stage. That’s not going to speed things up. Understand the law First, let’s admit DSCSA is complex and opaque and clarify exactly what the law requires that you, the contract manufacturer, complete by Nov. 27, 2017. The requirements are probably less onerous than you think. There are two key items that need to be implemented by Nov. 27, 2017:
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !